Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 800 | 866 | 1,312 | 617 | 521 |
| Operating Income | -800 | -866 | -1,312 | -617 | -521 |
| Interest Expense | 80 | 136 | 79 | 191 | 141 |
| Other Income | 29 | -58 | -89 | -9 | -285 |
| Pre-tax Income | -850 | -1,059 | -1,479 | -816 | -947 |
| Net Income Continuous | -850 | -1,059 | -1,479 | -816 | -947 |
| Net Income | $-850 | $-1,059 | $-1,479 | $-816 | $-947 |
| EPS Basic Total Ops | -0.01 | 1.22 | -0.01 | -0.01 | -1.42 |
| EPS Basic Continuous Ops | -0.01 | 1.32 | -0.07 | -0.01 | -1.42 |
| EPS Diluted Total Ops | -0.01 | 1.22 | -0.01 | -0.01 | -1.42 |
| EPS Diluted Continuous Ops | -0.01 | 1.32 | -0.07 | -0.01 | -1.42 |
| EBITDA(a) | $-750 | $-793 | $-1,248 | $-482 | $-418 |